Febrile neutropenia/antifungal drug trial design
Executive Summary
FDA will hold a public workshop on clinical trial design for febrile neutropenia and antifungal combination therapies on Sept. 4. The meeting, co-sponsored by the National Institute of Allergy & Infectious Diseases, will take place at the Hyatt Regency in Bethesda, Md., beginning at 1 p.m. [To view a webcast or live videoconference of this meeting, contact [email protected] or call 800-332-1370 ext. 7210]...